MedPath

Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation

Not Applicable
Withdrawn
Conditions
Bipolar Disorder
Schizophrenia
Healthy Controls
Interventions
Device: Magnetic resonance spectroscopy (MRS)
Registration Number
NCT00801567
Lead Sponsor
Mclean Hospital
Brief Summary

This study aims to gather additional information to support the theory that bipolar disorder is due to cellular (mitochondrial) dysfunction. To test this theory adults with bipolar disorder who are not currently symptomatic will receive a one-time brain scan (magnetic resonance spectroscopy \[MRS\] scan) with light stimulation. To test whether any MRS findings are specific to bipolar disorder, healthy controls and adults with schizophrenia will also be included in this study.

Detailed Description

This study will include males and females between the ages of 18 and 55 years. Participants will include adults with stable bipolar disorder or schizophrenia as well as healthy controls. The study involves a one-time visit that includes a clinical evaluation, laboratory tests, and a magnetic resonance scan that will last approximately 90 minutes. The procedures can also be separated into two study visits, if necessary.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Male of female
  • 18-55 years
  • Bipolar, currently euthymic OR schizophrenia, stable, OR healthy control with no history of psychiatric illness
  • On stable medication with no changes in the two weeks prior to enrollment
Exclusion Criteria
  • History of substance abuse or dependence within 3 months of enrollment
  • Positive urine drug screen
  • Significant medical or neurological illness
  • Pregnancy
  • Any contraindication to magnetic resonance scanning, including claustrophobia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Magnetic resonance spectroscopy (MRS)All subjects will receive the intervention (MRS scan).
Primary Outcome Measures
NameTimeMethod
Change in brain levels of phosphocreatine (PCr), beta-nucleoside triphosphate (B-NTP), and intracellular pH (pHi).42 minutes
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath